Going to EACR? Join ArcherDX at EACR24 for in-booth presentations on Archer® FusionPlex® NGS assays and Archer Analysis bioinformatics software to detect known and novel gene fusions, point mutations and relative expression levels.
Sunday 7/10 at 10:20
“Anchored Multiplex PCR (AMP™) chemistry enables comprehensive mutation profiling of tumors by next-generation sequencing”
Sunday 7/10 at 15:50
“Archer Analysis enables automated, rapid detection of fusions, CNVs, SNVs and indels from next-generation sequencing data”
Monday 7/11 at 10:20
“Detect novel fusions and other mutations in genes associated with a variety of carcinomas with the Archer FusionPlex Solid Tumor kit”
Monday 7/11 at 15:50
“The Archer FusionPlex Sarcoma kit enables detection of novel gene fusions and other mutations in genes associated with soft-tissue cancers”
We address the bottlenecks associated with using NGS in oncogenic mutation detection by offering a robust platform for targeted sequencing. By combining proprietary AMP chemistry with easy-to-use, lyophilized reagents, Archer NGS assays generate highly enriched sequencing libraries to detect gene fusions, point mutations, CNVs and RNA abundance. Complemented by powerful bioinformatics software, ArcherDX technology dramatically enhances complex mutation identification and discovery.
Josh was born and raised in Baltimore, MD and studied biochemistry and molecular biology at West Virginia University. After graduation, he was drawn to Colorado by the snow and mountains. He went to graduate school at the University of Colorado Boulder, where he studied small-molecular perturbation of the TLDR4/MD-2 protein interaction and its effect on morphine analgesia. He joined ArcherDX when the company was in its infancy, specifically to be part of something that would make a lasting impact on healthcare. Josh enjoys skiing, off-roading, mountain biking and playing with his dog Skye.
Darius is a Colorado native who obtained his BA in integrated physiology and is now an MBA candidate at the University of Colorado, Boulder. He joined ArcherDx in early 2014 after pursuing several Boulder-based tech ventures. He is currently a product manager for custom and blood cancer-related NGS assays
2477 55th Street, Suite 202
Boulder, CO 80301